Keywords: Sanofi, SkyePharma, Flutiform, Mexico, Central and South America, Asthma

Sanofi gets rights to SkyePharma’s Flutiform in Mexico, Central and South America

Article | 29 July 2011

Print This

UK-based SkyePharma (LSE: SKP) says it has entered into an exclusive development, license and marketing agreement with French drug major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in